SCHEMBL31157553

SCHEMBL31157553

CN(C)C(=O)N1CCC(n2cc(C(=O)O)c(=O)c3cc(Cl)c(N4Cc5cccnc5C4)cc32)CC1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 7/20 0.51
▸ KDM4E B2RXH2 4/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ PIK3CD O00329 4/20 0.41
▸ PIK3R1 P27986 4/20 0.41
▸ PIK3CA P42336 4/20 0.41
▸ LMNA P02545 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ TOP2A P11388 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ TOP2B Q02880 1/20 0.41
▸ GRM1 Q13255 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38
▸ HTT P42858 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31157573 0.91 KDM4E (0.53) PIK3CGKDM4EALDH1A1PIK3CDPIK3R1
SCHEMBL31157507 0.90 PIK3CG (0.53) PIK3CGKDM4EALDH1A1PIK3CDPIK3R1
SCHEMBL31157577 0.88 PIK3CG (0.55) PIK3CGKDM4EALDH1A1PIK3CDPIK3R1
SCHEMBL31157468 0.87 PIK3CG (0.44) PIK3CGKDM4EALDH1A1PIK3CDPIK3R1
Hydrochloric Acid SCHEMBL31157444 0.85 PIK3CG (0.50) PIK3CGKDM4EALDH1A1PIK3CDPIK3R1
SCHEMBL9316471 0.79 PIK3CG (0.65) PIK3CGKDM4EALDH1A1PIK3CDPIK3R1
SCHEMBL31157594 0.79 PIK3CG (0.45) PIK3CGKDM4EALDH1A1PIK3CDPIK3R1
SCHEMBL31157523 0.77 PIK3CG (0.45) PIK3CGKDM4EALDH1A1LMNAHPGD
SCHEMBL31157397 0.76 PIK3CG (0.45) PIK3CGKDM4EALDH1A1LMNAHPGD
SCHEMBL31157413 0.75 CAPN1 (0.48) PIK3CGKDM4EALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376100-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1, 4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES Redona Therapeutics, Inc. 2024-11-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376100-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1, 4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES PAPSS1, OTUD7B, BRD7 PIK3CG 2909/4885KDM4E 2402/4885ALDH1A1 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback